Amanote Research
Register
Sign In
Why Most Budget Impact Analyses of Medicines Are Not Accurate? Quality of Budget Impact Analysis Needs to Be Improved
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.04.762
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
May 1, 2018
Authors
JC Hsu
M Ho
T Tsai
M Wu
Publisher
Elsevier BV
Related search
Perioperative Antibiotic Prophylaxis: Budget Impact Analysis
Vestnik of Saint Petersburg University. Medicine
Budget Impact of Publicly Reimbursed Prescription Medicines in the Republic of Srpska
Frontiers in Public Health
Environmental
Public Health
Occupational Health
Php143 - Economic Evaluations and Budget Impact Analyses of Innovative Medicines According to the Catalan Health Service Standards: A Qualitative Assessment
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Budget Impact Analysis of Vildagliptin Treating T2dm in China
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn80 - Budget Impact Analysis With Use of Subcutaneus Trastuzumab
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pmu29 - Evaluating Budget Impact Analyses for Extramural Drugs in the Netherlands
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Budget Impact Analysis of Adalimumab Biosimilar: The Italian Context
AboutOpen
Php348 - Regenerative Medicine Advanced Therapy: A Budget Impact Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Budget Impact Analysis of Apixaban to Treat and Prevent Venous Thromboembolism in Italy
Farmeconomia. Health economics and therapeutic pathways
